Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections June 2023 | Nature Communications
A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice May 2022 | Science Translational Medicine
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells February 2022 | Nature
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation November 2019 | Nature Cancer
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques September 2017 | Science